Table 1 Study and patient characteristics
From: Clinical outcomes in patients co-infected with COVID-19 and Staphylococcus aureus: a scoping review
First Author | Country | Publication date | Study design | Quality Assessment | N | Age | Male/Female | Type | Co-infection | Comorbidities | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|
Adachi | Japan | 05/15/20 | Case report | 8/8 | 1 | 84 | Female | MSSA | Klebsiella pneumoniae | None | Death |
Bagnato | Italy | 08/05/20 | Case report | 8/8 | 1 | 62 | Female | MSSA | Candida tropicalis | Hypertension | Discharge |
Chandran | United Kingdom | 05/20/21 | Case report | 7/8 | 1 | NR | Female | MSSA | None | Type 2 diabetes mellitus | Death |
Chen | China | 11/01/20 | Case report | 6/8 | 1 | 29 | Male | MSSA and MRSA | Haemophilus influenzae | NR (not reported) | Discharge |
Choudhury | USA | 07/04/20 | Case report | 7/8 | 1 | 73 | Male | MSSA | None | Type 2 diabetes mellitus, chronic foot osteomyelitis, aortic stenosis, prosthetic aortic valve, atrial fibrillation, prior S. aureus infection | Hospice |
Cusumano | USA | 11/12/20 | Case series | 9/10 | 42 | 65.6 (mean) | Males (n = 21), Females (n = 21) | MSSA (n = 23) and MRSA (n = 19) | Enterococcus faecalis (n = 3), Candida spp. (n = 2), Klebsiella pneumoniae (n = 2), Escheria coli (n = 1), Bacillus spp. (n = 1), Micrococcus spp. (n = 1), Staphylococcus epidermidis (n = 1), Proteus mirabilis (n = 1) | Hypertension (n = 29), diabetes mellitus (n = 21), cardiovascular disease (n = 19), lung disease (n = 7), chronic kidney disease (n = 6), malignancy (n = 5), end-stage renal disease (n = 4), organ transplant (n = 3), liver disease (n = 1) | Death at 30 days (n = 28) |
De Pascale | Italy | 05/31/21 | Prospective cohort | 8/11 | 40 | 64 (mean) | Males (n = 33), Females (n = 7) | MSSA (n = 14), MRSA (n = 26) | Bacteroidetes (n = 18), Proteobacteria (n = 7), Actinobacteria (n = 3), Tenericutes (n = 2), Fusobacteria (n = 1)1 | Diabetes mellitus (n = 8), cardiovascular disease (n = 7), lung disease (n = 7), immunosuppression (n = 4), neoplasm (n = 4), chronic kidney disease (n = 3) | Death (n = 26) |
Duployez | France | 04/16/20 | Case report | 8/8 | 1 | 35 | Male | MSSA (PVL-secreting) | None | None | Death |
Edrada | Philippines | 05/07/20 | Case report | 6/8 | 1 | 39 | Female | MSSA | Influenza B, Klebsiella pneumoniae | None | Discharge |
ElSeirafi | Bahrain | 06/23/20 | Case report | 6/8 | 1 | 59 | Male | MRSA | None | NR | Death |
Filocamo | Italy | 05/11/20 | Case report | 8/8 | 1 | 50 | Male | MSSA | None | None | Discharge |
Hamzavi | Iran | 08/01/20 | Case report | 6/8 | 1 | 14 | Male | MSSA | None | Cerebral palsy | Death |
Hoshiyama | Japan | 11/02/20 | Case series | 6/10 | 1 | 47 | Male | MSSA | None | Previous cerebral hemorrhage | Discharge |
“” | “” | “” | “” | “” | 1 | 39 | Male | MSSA | Group B Streptococcus | Hypertension | Discharge |
Hussain | United Kingdom | 05/22/20 | Case report | 8/8 | 1 | 69 | Female | MSSA | None | Prosthetic aortic valve with reduced ejection fraction | Death |
Levesque | Canada | 07/01/20 | Case report | 6/8 | 1 | 53 | Female | MSSA | None | Hypertension, diabetes mellitus, dyslipidemia | Hospital |
Mirza | USA | 11/16/20 | Case report | 6/8 | 1 | 29 | Male | MRSA | Multi-drug resistant Pseudomonas | Cystic fibrosis with moderate obstructive lung disease, exocrine pancreatic insufficiency, gastroparesis, chronic S. aureus | Discharge |
Patek | USA | 04/15/20 | Case report | 7/8 | 1 | 0 | Male | MSSA | Herpes simplex virus | Maternal history of oral herpetic lesions | Discharge |
Posteraro | Italy | 09/06/20 | Case report | 8/8 | 1 | 79 | Male | MRSA | Morganella morganii, Candida glabrata, Acinetobacter baumannii, Proteus mirabilis, Klebsiella pneumoniae, Escherichia coli | Type 2 diabetes mellitus, ischemic heart disease, peripheral artery disease, left leg amputation | Death |
Rajdev | USA | 09/10/20 | Case report | 7/8 | 1 | 32 | Male | MSSA | Klebsiella pneumoniae | Type 2 diabetes mellitus | Discharge |
Rajdev | USA | 09/28/20 | Case report | 7/8 | 1 | 36 | Male | MSSA | Haemophilus influenzae | Hypertension, two renal transplants for renal dysplasia | Discharge |
Ramos-Martinez | Spain | 07/30/20 | Prospective cohort | 6/11 | 1 | 60 | NR | MSSA | None | Type 2 diabetes mellitus, hypercholesterolemia, wrist arthritis, sternoclavicular arthritis | Death |
Randall | USA | 12/01/20 | Case report | 7/8 | 1 | 60 | Male | MRSA | None | Chronic obstructive lung disease, coronary artery disease, hypothyroidism | Death |
“” | “” | “” | “” | “” | 1 | 83 | Male | MRSA | None | Hypertension, atrial fibrillation | Death |
“” | “” | “” | “” | “” | 1 | 60 | Male | MRSA | Hepatitis C | Hypertension, type 2 diabetes mellitus, cirrhosis | Death |
Regazzoni | Italy | 08/07/20 | Case report | 2/8 | 1 | 70 | Male | MSSA | None | NR | Hospital |
Sharifipour | Iran | 09/01/20 | Prospective cohort | 7/11 | 1 | NR | NR | MSSA | None | None | Discharge |
“” | “” | “” | “” | 1 | NR | NR | MRSA | None | Type 2 diabetes mellitus | Death | |
Son | Korea | 06/16/21 | Retrospective cohort | 8/11 | 4 | 79 (mean) | Male (n = 3), Female (n = 1) | MRSA | C. albicans (n = 2), Vancomycin-resistant enterococci (n = 2), S. maltophilia (n = 1) carbapenem-resistant Acinetobacter baumannii (n = 1), | NR | Death (n = 3) |
Spannella | Italy | 06/23/20 | Case report | 8/8 | 1 | 95 | Female | MSSA | Citrobacter werkmanii | Hypertension, chronic heart failure, paroxysmal atrial fibrillation, dyslipidemia, chronic kidney disease, vascular dementia, sacral pressure ulcers, dysphagia | Death |
Spoto | Italy | 09/30/20 | Case report | 6/8 | 1 | 55 | Female | MSSA | None | Triple negative, BRCA1-related, right breast cancer with multiple bone metastasis, type 2 diabetes mellitus | Death |
Valga | Spain | 06/11/20 | Case report | 6/8 | 1 | 68 | Male | MSSA | None | Hypertension, type 2 diabetes mellitus, congestive heart failure, sleep apnea, ischemic heart disease, chronic kidney disease | Discharge |